CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siddique, M. M.
Right arrow Articles by Sabapathy, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siddique, M. M.
Right arrow Articles by Sabapathy, K.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 2245-2252, September 2005
© 2005 American Association for Cancer Research

Evidence for Selective Expression of the p53 Codon 72 Polymorphs: Implications in Cancer Development

Mobin M. Siddique1, Chowbay Balram3, Lucja Fiszer-Maliszewska6, Amit Aggarwal2, Angie Tan2, Patrick Tan2, Khee C. Soo4 and Kanaga Sabapathy1,5

Laboratories of 1 Molecular Carcinogenesis, 2 Molecular Genomics, 3 Clinical Pharmacology, 4 Photodynamic Diagnosis and Treatment, National Cancer Centre; 5 Department of Biochemistry, National University of Singapore, Singapore, Singapore; and 6 Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

Requests for reprints: Kanaga Sabapathy, Laboratory of Molecular Carcinogenesis, National Cancer Centre, 11 Hospital Drive, Singapore 169610, Singapore. Phone: 65-6436-8349; Fax: 65-6226-5694. E-mail: cmrksb{at}nccs.com.sg

Polymorphism at codon 72 of p53 results in either the arginine or proline form of p53, whose functional significance in carcinogenesis is controversial. We have investigated if the expression of these p53 polymorphs is selectively regulated, using mRNA from peripheral blood of healthy Asian (Chinese) and the Caucasian (Polish) arginine/proline (arg/pro) heterozygote subjects. Asians were found to preferentially express the pro allele whereas the Caucasians preferentially express the arg allele. On the contrary, about 75% of the heterozygote Chinese breast cancer patients preferentially expressed the arg allele, which rarely contained any somatic mutations. Moreover, histologically normal tissues from Chinese heterozygote breast cancer patients showed selective expression of the arg allele, in contrast to the preferential expression of the pro allele in heterozygote healthy normal breast tissues. Together, the data suggest that the expression of the different p53 polymorphs is selectively regulated in different ethnic populations, and that the arg allele is activated during cancer development in Asians. Thus, the expression status of the p53 polymorphs, rather than the genotypic status, might be a useful indicator for cancer susceptibility.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
S. S. Lum, H. W. Chua, H. Li, W.-F. Li, N. Rao, J. Wei, Z. Shao, and K. Sabapathy
MDM2 SNP309 G allele increases risk but the T allele is associated with earlier onset age of sporadic breast cancers in the Chinese population
Carcinogenesis, April 1, 2008; 29(4): 754 - 761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.